Akebia Therapeutics, Inc. (AKBA) SEC filings
AKBA SEC filings moved a median of 0.00% by the close. AKBA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AKBA overview →
69 measured AKBA SEC filing events.
Where these AKBA SEC filings landedvs 68 measured AKBA SEC filing reactions
| Middle 50% of AKBA SEC filing reactions | -5.05% to +4.21% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 68 |
Point-in-time · zero look-ahead
Half of the 68 AKBA SEC filing events with a measured close landed between -5.05% and +4.21%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Akebia Therapeutics, For: Oct 07 | SEC filing · Form 8-K | -0.05% | — | |
| Form 10-Q Akebia Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +7.13% | +8.20% | |
| Form 8-K Akebia Therapeutics, For: Aug 05 | SEC filing · Form 8-K | +7.13% | +8.20% | |
| Form S-8 Akebia Therapeutics, | SEC filing · Form S-8 | +7.13% | +8.20% | |
| Form 8-K Akebia Therapeutics, For: Jun 30 | SEC filing · Form 8-K | -6.31% | -10.24% | |
| Form 8-K Akebia Therapeutics, For: Jun 17 | SEC filing · Form 8-K | +1.38% | +0.92% | |
| Form 10-Q Akebia Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +3.98% | +4.42% | |
| Form 8-K Akebia Therapeutics, For: May 07 | SEC filing · Form 8-K | +3.98% | +4.42% | |
| Form ARS Akebia Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.43% | -2.86% | |
| Form DEF 14A Akebia Therapeutics, For: Apr 28 | SEC filing · Form DEF | -1.43% | -2.86% | |
| Form DEFA14A Akebia Therapeutics, | SEC filing · Form DEFA14A | -1.43% | -2.86% | |
| Form PRE 14A Akebia Therapeutics, For: Apr 15 | SEC filing · Form PRE | -0.97% | -12.34% | |
| Form 8-K Akebia Therapeutics, For: Mar 27 | SEC filing · Form 8-K | -0.72% | -0.72% | |
| Form 10-K Akebia Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -7.19% | -9.59% | |
| Form 8-K Akebia Therapeutics, For: Feb 26 | SEC filing · Form 8-K | -7.19% | -9.59% | |
| Form 8-K Akebia Therapeutics, For: Jan 27 | SEC filing · Form 8-K | -0.34% | -4.08% | |
| Form 8-K Akebia Therapeutics, For: Jan 12 | SEC filing · Form 8-K | -6.04% | -6.04% | |
| Form 8-K Akebia Therapeutics, For: Nov 28 | SEC filing · Form 8-K | +0.63% | -5.63% | |
| Form 8-K Akebia Therapeutics, For: Nov 12 | SEC filing · Form 8-K | +2.07% | +4.14% | |
| Form 10-Q Akebia Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -3.18% | -3.47% | |
| Form 8-K Akebia Therapeutics, For: Nov 10 | SEC filing · Form 8-K | -3.18% | -3.47% | |
| Form 8-K Akebia Therapeutics, For: Oct 28 | SEC filing · Form 8-K | +9.20% | -0.94% | |
| Form 10-Q Akebia Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -5.21% | -5.05% | |
| Form 8-K Akebia Therapeutics, For: Aug 07 | SEC filing · Form 8-K | -5.21% | -5.05% | |
| Form S-8 Akebia Therapeutics, | SEC filing · Form S-8 | -5.21% | -5.05% | |
| Form 8-K Akebia Therapeutics, For: Jun 10 | SEC filing · Form 8-K | -0.14% | -0.84% | |
| Form 10-Q Akebia Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.61% | -6.43% | |
| Form 8-K Akebia Therapeutics, For: May 08 | SEC filing · Form 8-K | -1.61% | -6.43% | |
| Form ARS Akebia Therapeutics, For: Apr 29 | SEC filing · Form ARS | +0.85% | +2.12% | |
| Form DEF 14A Akebia Therapeutics, For: Apr 29 | SEC filing · Form DEF | +0.85% | +2.12% | |
| Form DEFA14A Akebia Therapeutics, | SEC filing · Form DEFA14A | +0.85% | +2.12% | |
| Form 8-K Akebia Therapeutics, For: Mar 19 | SEC filing · Form 8-K | -0.95% | +4.41% | |
| Form 10-K Akebia Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.89% | -6.11% | |
| Form 8-K Akebia Therapeutics, For: Mar 13 | SEC filing · Form 8-K | -1.89% | -6.11% | |
| Form 8-K Akebia Therapeutics, For: Feb 03 | SEC filing · Form 8-K | -0.23% | -1.38% | |
| Form S-8 Akebia Therapeutics, | SEC filing · Form S-8 | +1.67% | +0.00% | |
| Form 8-K Akebia Therapeutics, For: Jan 13 | SEC filing · Form 8-K | +0.29% | +7.47% | |
| Form 10-Q Akebia Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.89% | +7.80% | |
| Form 8-K Akebia Therapeutics, For: Nov 07 | SEC filing · Form 8-K | -2.89% | +7.80% | |
| Form 8-K Akebia Therapeutics, For: Oct 22 | SEC filing · Form 8-K | +1.08% | +17.99% | |
| Form 8-K Akebia Therapeutics, For: Oct 15 | SEC filing · Form 8-K | -0.76% | +0.76% | |
| Form EFFECT Akebia Therapeutics, | SEC filing · Form EFFECT | +0.34% | +0.69% | |
| Form S-3 Akebia Therapeutics, | SEC filing · Form S-3 | -1.86% | +4.10% | |
| Form 10-Q Akebia Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -4.31% | +2.59% | |
| Form 8-K Akebia Therapeutics, For: Aug 08 | SEC filing · Form 8-K | -4.31% | +2.59% | |
| Form 8-K Akebia Therapeutics, For: Jul 10 | SEC filing · Form 8-K | -2.61% | +10.44% | |
| Form 8-K Akebia Therapeutics, For: Jun 21 | SEC filing · Form 8-K | -0.99% | -2.33% | |
| Form 8-K Akebia Therapeutics, For: Jun 06 | SEC filing · Form 8-K | +1.85% | +2.78% | |
| Form 10-Q Akebia Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.90% | +19.82% | |
| Form 8-K Akebia Therapeutics, For: May 09 | SEC filing · Form 8-K | -0.90% | +19.82% | |
| Form ARS Akebia Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.87% | +0.00% | |
| Form DEF 14A Akebia Therapeutics, For: Apr 25 | SEC filing · Form DEF | -1.87% | +0.00% | |
| Form DEFA14A Akebia Therapeutics, | SEC filing · Form DEFA14A | -1.87% | +0.00% | |
| Form 8-K Akebia Therapeutics, For: Apr 17 | SEC filing · Form 8-K | -0.72% | -0.72% | |
| Form 8-K Akebia Therapeutics, For: Apr 15 | SEC filing · Form 8-K | -1.49% | +1.45% | |
| Form 8-K Akebia Therapeutics, For: Mar 27 | SEC filing · Form 8-K | -12.99% | -25.91% | |
| Form 8-K Akebia Therapeutics, For: Mar 15 | SEC filing · Form 8-K | -2.00% | +8.00% | |
| Form 10-K Akebia Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.25% | +6.25% | |
| Form 8-K Akebia Therapeutics, For: Mar 14 | SEC filing · Form 8-K | -1.25% | +6.25% | |
| Form 8-K Akebia Therapeutics, For: Feb 08 | SEC filing · Form 8-K | -4.63% | -6.17% | |
| Form 8-K Akebia Therapeutics, For: Jan 29 | SEC filing · Form 8-K | -3.34% | -8.89% | |
| Form S-8 Akebia Therapeutics, | SEC filing · Form S-8 | -0.61% | +1.82% | |
| Form 8-K Akebia Therapeutics, For: Jan 08 | SEC filing · Form 8-K | -0.34% | +5.37% | |
| Form 8-K Akebia Therapeutics, For: Dec 14 | SEC filing · Form 8-K | -1.26% | +0.00% | |
| Form 8-K Akebia Therapeutics, For: Nov 21 | SEC filing · Form 8-K | +0.20% | -1.00% | |
| Form 10-Q Akebia Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -6.31% | -6.80% | |
| Form 8-K Akebia Therapeutics, For: Nov 08 | SEC filing · Form 8-K | -6.31% | -6.80% | |
| Form 8-K Akebia Therapeutics, For: Oct 31 | SEC filing · Form 8-K | -0.01% | +1.60% | |
| Form 8-K Akebia Therapeutics, For: Oct 25 | SEC filing · Form 8-K | -3.65% | +1.58% |
Keep exploring
More AKBA: earnings → · analyst actions → · AKBA overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Albireo Pharma, Inc. (ALBO) | 378 | +0.05% | 53% |
| REPRO MED SYSTEMS INC (REPR) | 378 | 0.00% | 26% |
| Amneal Pharmaceuticals, Inc. - Class A (AMRX) | 377 | -0.08% | 46% |
| Autolus Therapeutics plc - American Depositary Shares (AUTL) | 377 | -0.00% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.